INCURON

Pipeline

CBL137 Indication	Research	Pre-Clinical	Phase 1	Phase 2	Phase 3
Solid Tumors, IV administration, USA
Solid Tumors, Oral administration, RUS
Hematological Malignancies

Two posters with the results of completed clinical trials that described CBL0137 safety, pharmacokinetics, and efficacy in patients with advanced…

The results of two completed clinical trials of the curaxin CBL0137 (oral and intravenous administration) in patients with advanced solid…

The results of the research which describe the curaxin CBL0137 mechanism of action will be presented at the American Association…

info@incuron.com

73 High Street, Buffalo, NY 14203
Telephone/Fax: (716) 588-0007